Clinical Trials

Pharmaxis has conducted a number of clinical trials as part of the regulatory approvals process for Bronchitol.

Cystic Fibrosis (cont’d)

Phase II
Description CF202: Dosing Study
Sites Argentina , Canada
Subjects 48
Status Complete
More Information


Media Releases
Phase II
Description CF201: Proof of concept - ability to improve FEV1 and quality of life
Sites Australia
Subjects 40
Status Complete
More Information


PubMed PMID**

Media Releases is a service provided by the U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine. provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions. Pharmaxis chooses to publish all Pivotal Trials on the website.

** Pubmed is a service of the U.S. National Library of Medicine and the National Institutes of Health.

*** No further clinical development planned in Bronchiectasis